Global Research-grade Proteins Market Size Study, by Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins), by Host Cell (Mammalian Cells, Bacterial Cells), by End-use, and Regional Forecasts 2022-2032

Description

The Global Research-grade Proteins Market is valued at approximately USD 0.83 billion in 2023 and is anticipated to grow with a robust compound annual growth rate (CAGR) of 11.49% over the forecast period 2024-2032. Research-grade proteins are essential tools in the biomedical and biopharmaceutical industries, providing critical insights into cellular functions, therapeutic development, and disease mechanisms. These proteins, produced using advanced biotechnological processes, are highly pure and customizable, enabling their use in diverse applications such as drug discovery, diagnostic research, and academic studies. With escalating investments in biopharmaceutical research and an increasing emphasis on personalized medicine, the market for research-grade proteins is witnessing unprecedented growth.

Advancements in bioprocessing technologies have significantly influenced the market trajectory. Modern techniques, such as the use of mammalian cell cultures and bacterial expression systems, allow for the efficient production of high-quality proteins with precise post-translational modifications. This trend is augmented by increasing collaborations between academic institutions, research organizations, and industry players, fostering innovation and the development of novel protein-based solutions. Furthermore, the emergence of immune checkpoint proteins as pivotal tools in immunotherapy and oncology research has catalyzed demand, reinforcing the market's expansion.

The market's growth is driven by several factors, including the surging prevalence of chronic diseases and the heightened need for targeted therapeutic solutions. For instance, cytokines and growth factors are being extensively utilized to understand immune system responses and facilitate tissue regeneration. Notably, a marked increase in R&D spending by pharmaceutical and biotechnology companies, exceeding billions of dollars annually, underscores the commitment to harnessing the potential of research-grade proteins. However, the high costs associated with protein production and the complexities of ensuring consistent quality remain challenges that could hinder growth during the forecast period.

Regionally, North America dominates the Global Research-grade Proteins Market, primarily due to its advanced healthcare infrastructure, significant R&D investments, and the presence of key market players. The region's well-established biopharmaceutical sector serves as a catalyst for market progression. Europe also holds a substantial share, driven by a robust academic research base and increasing governmental support for biotechnological advancements. Meanwhile, the Asia Pacific region is poised to register the fastest growth over the forecast period, bolstered by rapidly developing biopharmaceutical industries in countries like China and India, coupled with increasing investments in healthcare infrastructure and research capabilities.

Major market players included in this report are:

Thermo Fisher Scientific, Inc.
Merck KGaA
Abcam plc
Bio-Techne Corporation
Sino Biological, Inc.
GenScript Biotech Corporation
Cell Signaling Technology, Inc.
Lonza Group AG
ProSpec-Tany TechnoGene Ltd.
Creative BioMart
R&D Systems
Enzo Life Sciences, Inc.
PeproTech, Inc.
ACROBiosystems
OriGene Technologies, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product:

Cytokines & Growth Factors
Antibodies
Immune Checkpoint Proteins

By Host Cell:

Mammalian Cells
Bacterial Cells

By End-use:

Biotechnology and Pharmaceutical Companies
Academic and Research Institutes

By Region:

North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa

Years considered for the study are as follows:

Historical Year - 2022
Base Year - 2023
Forecast Period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Research-grade Proteins Market Executive Summary

1.1. Global Research-grade Proteins Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
  - Cytokines & Growth Factors
  - Antibodies
  - Immune Checkpoint Proteins
- 1.3.2. By Host Cell
  - Mammalian Cells
  - Bacterial Cells
- 1.3.3. By End-use
  - Biotechnology and Pharmaceutical Companies
  - Academic and Research Institutes
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Research-grade Proteins Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Research-grade Proteins Market Dynamics

3.1. Market Drivers
- 3.1.1. Escalating Investments in Biopharmaceutical R&D
- 3.1.2. Advancements in Bioprocessing Technologies
- 3.1.3. Growing Demand for Personalized Therapeutics
- 3.1.4. Increasing Collaborative Efforts between Academia and Industry
3.2. Market Challenges
- 3.2.1. High Costs of Protein Production
- 3.2.2. Complexities in Quality Assurance and Consistency
- 3.2.3. Regulatory and Manufacturing Hurdles
3.3. Market Opportunities
- 3.3.1. Expansion of Targeted Therapeutic Applications
- 3.3.2. Rising Adoption of Immune Checkpoint Proteins in Immunotherapy
- 3.3.3. Growth Potential in Emerging Markets (Asia Pacific)

Chapter 4. Global Research-grade Proteins Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Research-grade Proteins Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Research-grade Proteins Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Cytokines & Growth Factors
- 5.2.2. Antibodies
- 5.2.3. Immune Checkpoint Proteins

Chapter 6. Global Research-grade Proteins Market Size & Forecasts by Host Cell 2022-2032

6.1. Segment Dashboard
6.2. Global Research-grade Proteins Market: Host Cell Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Mammalian Cells
- 6.2.2. Bacterial Cells

Chapter 7. Global Research-grade Proteins Market Size & Forecasts by End-use 2022-2032

7.1. Segment Dashboard
7.2. Global Research-grade Proteins Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Biotechnology and Pharmaceutical Companies
- 7.2.2. Academic and Research Institutes

Chapter 8. Global Research-grade Proteins Market Size & Forecasts by Region 2022-2032

7.1. North America
- 7.1.1. U.S. Research-grade Proteins Market
  - 7.1.1.1. By Product Breakdown Size & Forecasts, 2022-2032
  - 7.1.1.2. By Host Cell Breakdown Size & Forecasts, 2022-2032
- 7.1.2. Canada Research-grade Proteins Market
7.2. Europe
- 7.2.1. U.K. Research-grade Proteins Market
- 7.2.2. Germany Research-grade Proteins Market
- 7.2.3. France Research-grade Proteins Market
- 7.2.4. Spain Research-grade Proteins Market
- 7.2.5. Italy Research-grade Proteins Market
- 7.2.6. Rest of Europe Research-grade Proteins Market
7.3. Asia Pacific
- 7.3.1. China Research-grade Proteins Market
- 7.3.2. India Research-grade Proteins Market
- 7.3.3. Japan Research-grade Proteins Market
- 7.3.4. Australia Research-grade Proteins Market
- 7.3.5. South Korea Research-grade Proteins Market
- 7.3.6. Rest of Asia Pacific Research-grade Proteins Market
7.4. Latin America
- 7.4.1. Brazil Research-grade Proteins Market
- 7.4.2. Mexico Research-grade Proteins Market
- 7.4.3. Rest of Latin America Research-grade Proteins Market
7.5. Middle East & Africa
- 7.5.1. Saudi Arabia Research-grade Proteins Market
- 7.5.2. South Africa Research-grade Proteins Market
- 7.5.3. Rest of Middle East & Africa Research-grade Proteins Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Thermo Fisher Scientific, Inc.
- 9.1.2. Merck KGaA
- 9.1.3. Abcam plc
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Thermo Fisher Scientific, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Bio-Techne Corporation
- 9.3.3. Sino Biological, Inc.
- 9.3.4. GenScript Biotech Corporation
- 9.3.5. Cell Signaling Technology, Inc.
- 9.3.6. Lonza Group AG
- 9.3.7. ProSpec-Tany TechnoGene Ltd.
- 9.3.8. Creative BioMart
- 9.3.9. R&D Systems
- 9.3.10. Enzo Life Sciences, Inc.
- 9.3.11. PeproTech, Inc.
- 9.3.12. ACROBiosystems
- 9.3.13. OriGene Technologies, Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes